Paper
Document
Submit new version
Download
Flag content
0

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Authors
Saad Usmani,Fredrik Schjesvold
+101 authors
,Т. Чагорова
Published
Jul 18, 2019
Show more
Save
TipTip
Document
Submit new version
Download
Flag content
0
TipTip
Save
Document
Submit new version
Download
Flag content